相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases
Shi-Yang Guan et al.
INFLAMMATION (2017)
Decreased expression of Sema3A, an immune modulator, in blood sample of multiple sclerosis patients
Mahsa Rezaeepoor et al.
GENE (2017)
Semaphorin 3A: Is a key player in the pathogenesis of asthma
Ronen Cozacov et al.
CLINICAL IMMUNOLOGY (2017)
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis
Eloisa Romano et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
CLASS 3 SEMAPHORINS MODULATE THE INVASIVE CAPACITY OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES
S. Garcia Perez et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
B CELL DEPLETION THERAPY IN SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE. A MULTICENTER, OPEN LABEL, COMPARATIVE STUDY WITH A FOLLOW UP OF 94 PATIENT-YEARS
K. Melissaropoulos et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design
Ana Gutierrez-Franco et al.
CLINICAL IMMUNOLOGY (2016)
Emerging role of adipokines in systemic lupus erythematosus
Hong-Miao Li et al.
IMMUNOLOGIC RESEARCH (2016)
SEMAPHORIN 3A, AN IMMUNOREGULATOR AND POTENTIAL BIOMARKER FOR DISEASE SEVERITY IN SYSTEMIC SCLEROSIS
Z. Vadasz et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Immunological function of Blimp-1 in dendritic cells and relevance to autoimmune diseases
Sun Jung Kim
IMMUNOLOGIC RESEARCH (2015)
Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men
David Kremer et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions
C. Costa et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Semaphorin 3A, a potential immune regulator in Familial Mediterranean Fever
D Rimar et al.
Pediatric Rheumatology (2015)
The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)
Zahava Vadasz et al.
PLOS ONE (2015)
Semaphorin 3A: an immunoregulator in systemic sclerosis
Doron Rimar et al.
RHEUMATOLOGY INTERNATIONAL (2015)
Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men
David Kremer et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions
C. Costa et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
The Expansion of CD25highIL-10highFoxP3high B Regulatory Cells Is in Association with SLE Disease Activity
Zahava Vadasz et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
What is new in systemic lupus erythematosus
Inigo Rua-Figueroa Fernandez de Larrinoa
REUMATOLOGIA CLINICA (2015)
AB0114 Semaphorin3a and semaphorin4d in rheumatoid arthritis.
Y. Yoshida et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
LL-37: A NEW MARKER FOR INTERSTITIAL LUNG DISEASE (ILD) IN SYSTEMIC SCLEROSIS (SSC)?
M. Hizal et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Semaphorins: Their Dual Role in Regulating Immune-Mediated Diseases
Zahava Vadasz et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2014)
The importance of regulatory T-cell heterogeneity in maintaining self-tolerance
Xiaomei Yuan et al.
IMMUNOLOGICAL REVIEWS (2014)
Diagnostic criteria for systemic lupus erythematosus: A critical review
Cong Yu et al.
JOURNAL OF AUTOIMMUNITY (2014)
A regulatory role for CD72 expression on B cells in systemic lupus erythematosus
Zahava Vadasz et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Mortality and survival in systemic sclerosis: Systematic review and meta-analysis
Manuel Rubio-Rivas et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Decreased Semaphorin3A expression correlates with disease activity and histological features of rheumatoid arthritis
Shu Takagawa et al.
BMC MUSCULOSKELETAL DISORDERS (2013)
Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases
Hai-Feng Pan et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Emerging role of interleukin-22 in autoimmune diseases
Hai-Feng Pan et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis
Herena Eixarch et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Innate immunity in the central nervous system
Richard M. Ransohoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Semaphorin 3A-a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus
Z. Vadasz et al.
LUPUS (2012)
Differences between rheumatologists and other internists regarding diagnosis and treatment of systemic lupus erythematosus
Karoline Lerang et al.
RHEUMATOLOGY (2012)
Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus
Zahava Vadasz et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system
Gabriele Piaton et al.
BRAIN (2011)
Measles virus modulates dendritic cell/T-cell communication at the level of plexinA1/neuropilin-1 recruitment and activity
Hieu Tran-Van et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
The role of immune semaphorins in multiple sclerosis
Tatsusada Okuno et al.
FEBS LETTERS (2011)
Inhibition of CNS Remyelination by the Presence of Semaphorin 3A
Yasir A. Syed et al.
JOURNAL OF NEUROSCIENCE (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
The involvement of immune semaphorins and neuropilin-1 in lupus nephritis
Z. Vadasz et al.
LUPUS (2011)
Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis
Benjamin D. Solomon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
G. Ruiz-Irastorza et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Neuropilins and semaphorins - from angiogenesis to autoimmunity
Z. Vadasz et al.
AUTOIMMUNITY REVIEWS (2010)
Regulation of immune cell responses by semaphorins and their receptors
Hyota Takamatsu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
Human regulatory T cells in autoimmune diseases
Gregory L. Cvetanovich et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
The Neuroimmune Semaphorin-3A Reduces Inflammation and Progression of Experimental Autoimmune Arthritis
Alfonso Catalano
JOURNAL OF IMMUNOLOGY (2010)
Clinical Significance of Serum Levels of Vascular Endothelial Growth Factor, Angiopoietin-1, and Angiopoietin-2 in Patients with Rheumatoid Arthritis
Daitaro Kurosaka et al.
JOURNAL OF RHEUMATOLOGY (2010)
Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II
Hyota Takamatsu et al.
NATURE IMMUNOLOGY (2010)
Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas
Valeria Barresi et al.
NEUROPATHOLOGY (2010)
Effector and regulatory B cells: modulators of CD4+ T cell immunity
Frances E. Lund et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Surveillance of Antigen-Presenting Cells by CD4+CD25+Regulatory T Cells in Autoimmunity Immunopathogenesis and Therapeutic Implications
Sebastien Andre et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
The many faces of semaphorins: from development to pathology
L. Roth et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
SOLUBLE SEMAPHORIN 3A REGULATES THE IMMUNE RESPONSE
Laura Schlahsa et al.
HUMAN IMMUNOLOGY (2009)
Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages
Jong-Dae Ji et al.
HUMAN IMMUNOLOGY (2009)
Immune Semaphorins: Novel Features of Neural Guidance Molecules
Masayuki Mizui et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
Plexin-A4 negatively regulates T lymphocyte responses
Midori Yamamoto et al.
INTERNATIONAL IMMUNOLOGY (2008)
Evidence that cytokines play a role in rheumatoid arthritis
Fionula M. Brennan et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Semaphorins and their receptors in immune cell interactions
Kazuhiro Suzuki et al.
NATURE IMMUNOLOGY (2008)
Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?
Anna Williams et al.
BRAIN (2007)
Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction
Gaeelle Clavel et al.
CLINICAL IMMUNOLOGY (2007)
Changes in causes of death in systemic sclerosis, 1972-2002
Virginia D. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelia ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas
Ryosuke Osada et al.
HUMAN PATHOLOGY (2006)
Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization
Yves Lepelletier et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function
A Catalano et al.
BLOOD (2006)
A novel role for Sema3A in neuroprotection from injury mediated by activated microglia
HH Majed et al.
JOURNAL OF NEUROSCIENCE (2006)
Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A
H Kashiwagi et al.
BLOOD (2005)
Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis
O Distler et al.
CIRCULATION RESEARCH (2004)
Induction of neuropilins-1 and-2 and their ligands, Sema3A, Sema3F, and VEGF, during Wallerian degeneration in the peripheral nervous system
M Scarlato et al.
EXPERIMENTAL NEUROLOGY (2003)
Pathogenesis of systemic lupus erythematosus
CC Mok et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins
J Rieger et al.
GLIA (2003)
The function of semaphorins during nervous system development
R Fiore et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
Ontogeny of semaphorins 3A and 3F and their receptors neuropilins 1 and 2 in the kidney
Guillermo Villegas et al.
MECHANISMS OF DEVELOPMENT (2002)
Injury-induced class 3 semaphorin expression in the rat spinal cord
F De Winter et al.
EXPERIMENTAL NEUROLOGY (2002)
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis
A Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A pathogenic role for myelin-specific CD8+ T cells in a model for multiple sclerosis
ES Huseby et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Biological activity of soluble CD100.: II.: Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration
S Delaire et al.
JOURNAL OF IMMUNOLOGY (2001)
Expression of class 3 semaphorins and neuropilin receptors in the developing mouse tooth
S Loes et al.
MECHANISMS OF DEVELOPMENT (2001)
分享论文
